Acción 2802 AJINOMOTO CO., INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Ajinomoto Co., Inc.

Acciones

2802

JP3119600009

Mercado cerrado - Japan Exchange
Otros sitios de cotización
 08:00:00 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
5.775 JPY +1,57 % Gráfico intradía de Ajinomoto Co., Inc. +7,50 % +6,16 %
27/03 Transcript : Ajinomoto Co., Inc. - Analyst/Investor Day
26/03 Ajinomoto Co., Inc. mejora el medio de expansión de células iPS StemFit CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Ajinomoto : Enhancing Corporate Value through ASV Management
Ajinomoto : Sustainability Initiatives Aimed at Enhancement of Corporate Value
TechMagic, Inc. announced that it has received funding from a group of investors
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors
Ajinomoto Foods Restates Commitment to Quality Products
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research
Ribomic Enters Into Drug Research Collaboration with Ajinomoto
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
New acquisition to support global gene therapy manufacturing
Forge Biologics - Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Ajinomoto Co., Inc. übernimmt Forge Biologics für 620 Millionen Dollar1
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Ajinomoto Co., Inc. announces an Equity Buyback for 10,000,000 shares, representing 1.92% for ¥40,000 million.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 2802
  4. Noticias Ajinomoto Co., Inc.
  5. Otros idiomas